Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins (Q47853973)

6 February 2018

http://europepmc.org/abstract/MED/24954688

title

Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins (English)

1 reference

6 February 2018

http://europepmc.org/abstract/MED/24954688

author

Andrew Rowland

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954688%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Kyra J Barnes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954688%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Thomas M Polasek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954688%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

John O Miners

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954688%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

24 June 2014

1 reference

6 February 2018

http://europepmc.org/abstract/MED/24954688

published in

European Journal of Clinical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954688%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954688%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954688%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

1097-1106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954688%20AND%20SRC:MED&resulttype=core&format=json

Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Pharmacokinetics of verapamil in patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Effects of aging on the renal glomerulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Characterization of hepatic cytochrome p4503A activity in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Effects of renal failure on drug transport and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Pharmacokinetics, safety, and antihypertensive efficacy of losartan in combination with hydrochlorothiazide in hypertensive patients with renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

The effect of chronic renal failure on hepatic drug metabolism and drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Effect of uremic serum and uremic toxins on drug metabolism in human microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Characterization of uremic toxin transport by organic anion transporters in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Review on uremic toxins: classification, concentration, and interindividual variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Guanidino compounds in uraemic dialysed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Inhibitory effects of uraemic toxins 3-indoxyl sulfate andp-cresol on losartan metabolismin vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Cytochrome P450 and ischemic heart disease: current concepts and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Nonspecific binding of drugs to human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Hepatic clearance, but not gut availability, of erythromycin is altered in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Effects of uremic toxins on hepatic uptake and metabolism of erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Cytochrome P4502C9 activity in end‐stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

The "albumin effect" and in vitro-in vivo extrapolation: sequestration of long-chain unsaturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P450 2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potentia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Urinary excretion of the uraemic toxin p-cresol in the rat: contribution of glucuronidation to its metabolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Free drug metabolic clearance in elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-014-1709-7

A gas chromatographic-mass spectrometric analysis for phenols in uremic serum

21 January 2018

1 reference

12 December 2020

Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis

1 reference

12 December 2020

Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases

1 reference

12 December 2020

Binding of hippurate in normal plasma and in uremic plasma pre- and postdialysis

1 reference

12 December 2020

Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure

1 reference

12 December 2020

Alteration of drug-protein binding in renal disease

1 reference

12 December 2020

Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis

1 reference

12 December 2020

Changes in erythromycin pharmacokinetics induced by renal failure.

1 reference

12 December 2020

Zidovudine disposition in patients with severe renal impairment: influence of hemodialysis

1 reference

12 December 2020

Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood

1 reference

12 December 2020

Acyclovir kinetics in end-stage renal disease

1 reference

12 December 2020

Clinical pharmacokinetics of nimodipine in normal and impaired renal function

1 reference

12 December 2020

Delayed elimination of SN-38 in cancer patients with severe renal failure

1 reference

12 December 2020

Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment

1 reference

12 December 2020

Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure

1 reference

12 December 2020

Warning: the unfortunate end of p-cresol as a uraemic toxin

1 reference

12 December 2020

Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2.

1 reference

12 December 2020

Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).

1 reference

12 December 2020

Free phenols in chronic renal failure

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation

1 reference

12 December 2020

Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis

1 reference

12 December 2020

Endothelin B receptor-mediated regulation of ATP-driven drug secretion in renal proximal tubule.

1 reference

12 December 2020

Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques

1 reference

12 December 2020

Uremic toxicity: present state of the art.

1 reference

12 December 2020

Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2

1 reference

12 December 2020

In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction

1 reference

12 December 2020